211 related articles for article (PubMed ID: 10415910)
1. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
Olmos G; Alemany R; Boronat MA; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes.
Olmos G; Alemany R; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):709-16. PubMed ID: 8971730
[TBL] [Abstract][Full Text] [Related]
3. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
4. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
5. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
Hosseini AR; King PR; Louis WJ; Gundlach AL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
[TBL] [Abstract][Full Text] [Related]
6. Isothiocyanatobenzyl imidazoline is an alkylating agent for I2-imidazoline binding sites in rat and rabbit tissues.
Boronat MA; Olmos G; Miller DD; Patil PN; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):351-5. PubMed ID: 9550309
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the imidazoline I2b-binding sites in the hamster brown adipose tissue as a study model for imidazoline receptors.
Römer L; Wurster S; Savola JM; Raasmaja A
Arch Physiol Biochem; 2003 Apr; 111(2):159-66. PubMed ID: 12919003
[TBL] [Abstract][Full Text] [Related]
8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.
Escribá PV; Ozaita A; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():8-25. PubMed ID: 10415892
[TBL] [Abstract][Full Text] [Related]
11. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1996 May; 304(1-3):221-9. PubMed ID: 8813605
[TBL] [Abstract][Full Text] [Related]
12. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
Wiest SA; Steinberg MI
Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
[TBL] [Abstract][Full Text] [Related]
13. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.
Lione LA; Nutt DJ; Hudson AL
Eur J Pharmacol; 1998 Jul; 353(1):123-35. PubMed ID: 9721049
[TBL] [Abstract][Full Text] [Related]
14. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
15. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine.
Wiest SA; Steinberg MI
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):209-16. PubMed ID: 10494892
[TBL] [Abstract][Full Text] [Related]
16. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
17. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
MacKinnon AC; Redfern WS; Brown CM
Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
Escribá PV; Alemany R; Sastre M; Olmos G; Ozaita A; García-Sevilla JA
Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539
[TBL] [Abstract][Full Text] [Related]
19. Expression of I2-imidazoline sites in rat prostate. Effect of castration and aging.
Regunathan S; Nassir Y; Sundaram K; Vaughan ED; Reis DJ; Felsen D
Biochem Pharmacol; 1996 Feb; 51(4):455-9. PubMed ID: 8619890
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
